A Comparative Analysis of Deaths Due to Drug‐Related Causes Between Rural and Urban Areas in the United Kingdom, 1997–2026
Drug and Alcohol Review · 2026-11 · 45 (7)
DOI: 10.1111/dar.70285 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug and Alcohol Review, online erschienen am 28.10.2026. Verfasst von Emmert Roberts und 2 weiteren Autor:innen. Beteiligte Einrichtung: National Addiction Centre, King's College London, London, UK. Hauptthemen laut MEDLINE: Urban Population, Rural Population, Substance-Related Disorders. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research, Royal Society of Medicine, CIHR.
Abstract (Originalsprache)
Introduction
Multiple jurisdictions report disproportionately elevated rates of drug‐related harm in urban settings, alongside unique treatment needs in rural populations. We examined differences in case characteristics, circumstances of death and implicated drugs among individuals dying from drug‐related causes, stratified by rural or urban setting, and determined changes in the proportion of deaths between settings over time.
Methods
Retrospective registry‐based analysis of coronial records of individuals who died from drug‐related causes, submitted to the National Programme on Substance Use Mortality in the UK, 1997–2026. UK Government Rural–Urban Classification methodology dichotomised cases using postcode at date of death.
Results
Overall, 39,975 decedents died, 36,350 (90.9%) in urban settings. The urban percentage decreased significantly over the study period from 96.6% in 1999 to 92.3% in 2025 (AAPC −0.34%, 95% CI −0.47% to −0.15%, p = 0.002). Accidental poisoning was the most common direct cause of death in both rural (45.5%) and urban (54.8%) settings, while intentional self‐poisoning was more common rurally (17.3% vs. 9.5%). Opioids were the most frequently implicated drug group in both rural (61.1%) and urban (65.4%) settings. The median number of drugs implicated did not differ significantly between settings (both 2, IQR 1–3), but rural decedents had a significantly higher median number of prescribed implicated drugs (1, IQR 0–2 vs. 0, IQR 0–2). Discussion and Conclusions Over three decades, approximately one in 11 UK drug‐related deaths occurred rurally. Intentional self‐poisoning was substantially more common in rural fatalities, and opioids were the leading implicated drug group across both settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Addiction Centre, King's College London, London, UK.
- South London and the Maudsley NHS Foundation Trust, London, UK.
- Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
- Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Canada.
ORCID-Profile: Emmert Roberts, Jürgen Rehm, Caroline Copeland
Förderung
- National Institute for Health and Care Research
- Royal Society of Medicine
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Roberts, E., Rehm, J., & Copeland, C. (2026). A Comparative Analysis of Deaths Due to Drug‐Related Causes Between Rural and Urban Areas in the United Kingdom, 1997–2026. Drug and Alcohol Review, 45(7). https://doi.org/10.1111/dar.70285
Vancouver
Roberts E, Rehm J, Copeland C. A Comparative Analysis of Deaths Due to Drug‐Related Causes Between Rural and Urban Areas in the United Kingdom, 1997–2026. Drug and Alcohol Review. 2026;45(7). doi:10.1111/dar.70285
BibTeX
@article{Roberts2026,
author = {Roberts, Emmert and Rehm, Jürgen and Copeland, Caroline},
title = {A Comparative Analysis of Deaths Due to Drug‐Related Causes Between Rural and Urban Areas in the United Kingdom, 1997–2026},
journal = {Drug and Alcohol Review},
year = {2026},
volume = {45},
number = {7},
doi = {10.1111/dar.70285}
}
EUVIMED